These were genuinely excellent companies. Many of them still exist and still thrive. Investors who bought them at the wrong price waited a decade or more just to break even.
In the late 1960s and early 1970s, a group of large American companies came to hold a special place in the minds of institutional investors. They were called the Nifty Fifty, and the list included household names in consumer goods, pharmaceuticals, photography, and technology. What tied them together was a reputation for growth so reliable, so durable, that they were described as one-decision stocks: securities you could buy and never have to think about again, because their prospects were treated as essentially guaranteed.
The reasoning behind that reputation wasn't foolish, and it's worth saying so plainly. These were, mostly, genuinely excellent businesses. They had strong brands, dominant market positions, consistent profitability, and long records of growth. An investor judging them purely on business quality would have reached entirely favorable conclusions, and would have been right to. The businesses were never the problem.
The price was the problem. Because these companies were treated as sure things, investors became willing to pay prices that reflected that certainty. Many of the Nifty Fifty traded at earnings multiples several times the market average, some above fifty or even eighty times annual earnings. A price like that embeds an extraordinary assumption: that rapid growth continues for a very long time, uninterrupted, unthreatened by competition, with no disappointment whatsoever. The price had stopped being a judgment about a business and become a statement of faith.
The bear market of 1973-74 tested that faith hard. As broad markets fell, the Nifty Fifty fell further than most, for reasons that had little to do with how the businesses were actually performing. When a stock is priced for perfection, anything short of perfection triggers a revaluation, and the revaluation is brutal precisely because the price had assumed so much. Many of these companies saw their shares cut by more than half, some by considerably more, while the underlying businesses kept operating just fine.
That's the heart of the episode, and the reason it stays instructive decades later. The companies didn't fail. Plenty of them kept growing, kept earning, and remain substantial enterprises today. An investor who had judged their business quality wasn't wrong about the business quality. They were wrong about something else entirely: the price they'd paid for that quality, and the record shows that this second error alone was enough to produce a poor outcome, no matter how correct the first judgment was.
The recovery varied a lot across the group, and that variation itself teaches something. Some of these companies eventually rewarded patient holders handsomely; an investor who bought at the peak and held for decades would, in several cases, have done fine in the end. Others took ten years or more just to get back to their old prices, and a few never justified what had been paid for them. What decided the outcome wasn't whether the company was good, since most of them were. It was how much of the company's future had already been paid for at the moment of purchase.
The episode is the clearest demonstration available of a distinction that quality-focused investors have to hold onto constantly: the merit of a business and the merit of investing in that business at a given price are two separate questions with two separate answers. A wonderful company bought at an indefensible price is not a wonderful investment, and no amount of admiration for the enterprise changes that. Price isn't a detail to settle after the real analysis is done. It is half the analysis.
The vocabulary of the period carries its own lesson. The phrase "one-decision stock" concedes something remarkable. It openly proposes that an investor need not think again, that the question of value has been permanently settled, that vigilance is unnecessary. Any framework that offers to relieve an investor of the obligation to keep thinking deserves suspicion, and the fact that this particular framework came from sophisticated institutions rather than amateurs is exactly what makes it worth remembering.
The pattern keeps recurring, and it keeps recurring with businesses that genuinely deserve their reputations. Every era produces companies so obviously excellent that their excellence seems to remove the need for price discipline, and in every era investors find out that it doesn't. The names change. The reasoning doesn't. An investor who catches themselves thinking a company is so good the price barely matters has arrived at exactly the thought the Nifty Fifty buyers arrived at, and history's verdict on that thought isn't ambiguous.
Why a very high earnings multiple is so unforgiving is usually felt rather than understood. It's simple enough to spell out. Pay fifty or eighty times a company's annual earnings and you're paying for many years of future profit in advance; the price can only be justified if those profits grow substantially and keep growing for a long time. That means the price contains not just an expectation of success, but an expectation of sustained, uninterrupted, above-average success stretching well into the future. Any deviation from that path, even a small one, even a temporary one, chips away at what the price assumed. The stock becomes vulnerable not just to failure but to ordinary disappointment, and ordinary disappointment happens to nearly every business eventually. A high multiple makes a stock expensive, and more importantly, fragile.
At VESTFY™, we treat the Nifty Fifty as the essential companion to any discussion of quality investing, because it's the episode that keeps quality honest. Owning excellent businesses is a sound ambition. Paying any price for them is not, and the gap between those two ideas has cost investors more, over the decades, than bad companies ever have.